Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions
暂无分享,去创建一个
Kiwon Jung | Ki Sung Kang | Chang-Eop Kim | K. Kang | Dahae Lee | Ki Hyun Kim | Dahae Lee | Chang-Eop Kim | Hye Lim Lee | K. Jung | H. Lee
[1] Joseph B. Martin. Huntington's disease , 1984, Neurology.
[2] L. Xiong,et al. Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats , 2011, Neurochemistry International.
[3] D. Butterfield,et al. Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil cortical synaptosomes , 1995, Neuroscience.
[4] N. Fuzzati. Analysis methods of ginsenosides. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] X. Jia,et al. Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses. , 2014, International immunopharmacology.
[6] Y. Ihara,et al. Lewy bodies are ubiquitinated , 1988, Acta Neuropathologica.
[7] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[8] L. Xiong,et al. Ginsenoside Rd promotes glutamate clearance by up-regulating glial glutamate transporter GLT-1 via PI3K/AKT and ERK1/2 pathways , 2013, Front. Pharmacol..
[9] Dong-Hyun Kim. Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng , 2012, Journal of ginseng research.
[10] G. Zhao,et al. Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia , 2011, Neuroscience.
[11] D. Dickson,et al. Pathology and Biology of the Lewy Body , 1993, Journal of neuropathology and experimental neurology.
[12] A. Lees,et al. A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease , 1997, Journal of neurochemistry.
[13] Shao Li,et al. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease , 2016, Neuropharmacology.
[14] X. Jia,et al. Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats , 2014, Journal of ginseng research.
[15] B. Hyman,et al. Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.
[16] K. Lange,et al. Pathogenesis of Parkinson's disease. , 1992, Current opinion in neurology and neurosurgery.
[17] Q. Li,et al. Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus , 2011, Neuroscience.
[18] 박종대. 고려인삼의 화학성분에 관한 고찰 ( Recent Studies on the Chemical Constituents of Korean Ginseng ) , 1996 .
[19] B. Zhu. CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. , 2004, International journal of molecular medicine.
[20] T. Sakata,et al. Central Effects of Ginsenosides on the Feeding Behavior and Response to Stress in Rats , 1987 .
[21] Yifa Zhou,et al. Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. , 2009 .
[22] D. Butterfield,et al. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.
[23] Hairong Cheng,et al. Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. , 2010, Journal of ethnopharmacology.
[24] Jin Sun,et al. Ginseng for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. , 2015, Current topics in medicinal chemistry.
[25] Hee-Young Yang,et al. Antioxidant enzymes as redox-based biomarkers: a brief review , 2015, BMB reports.
[26] S. Kwon,et al. Ginsenosides protect striatal neurons in a cellular model of Huntington's disease , 2009, Journal of neuroscience research.
[27] O. Tanaka,et al. STUDIES ON THE CONSTITUENTS OF JAPANESE AND CHINESE CRUDE DRUGS. XI. PANAXADIOL, A SAPOGENIN OF GINSENG ROOTS. , 1963, Chemical & pharmaceutical bulletin.
[28] M. Yoshikura,et al. [Studies on the components of Panax ginseng C.A. Meyer. V. On the structure of a new acetylene derivative "Panaxynol" (3). Synthesis of 1,9-(cis)-heptadecadiene-4,6-diyn-3-ol]. , 1966, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[29] Hairong Cheng,et al. The inhibitory effect of ginseng pectin on L-929 cell migration , 2010, Archives of pharmacal research.
[30] Yan Liu,et al. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats. , 2013, European journal of pharmacology.
[31] E. Ling,et al. Protective effects of ginseng on neurological disorders , 2015, Front. Aging Neurosci..
[32] S. Y. Choi,et al. Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng? , 2001, Journal of Korean medical science.
[33] J. Andersen,et al. Oxidative stress in neurodegeneration: cause or consequence? , 2004, Nature Reviews Neuroscience.
[34] B. Marchetti,et al. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? , 2005, Trends in pharmacological sciences.
[35] S. Helms. Cancer prevention and therapeutics: Panax ginseng. , 2004, Alternative medicine review : a journal of clinical therapeutic.
[36] Hyeyoung Min,et al. Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System , 2012, Journal of ginseng research.
[37] Elena Cattaneo,et al. Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.
[38] H. Zhai,et al. Effects of Ginsenoside Rg1 on the Expression of Toll-Like Receptor 3, 4 and Their Signalling Transduction Factors in the NG108-15 Murine Neuroglial Cell Line , 2014, Molecules.
[39] Y. Liu,et al. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease , 2015, Journal of ginseng research.
[40] O. Hornykiewicz. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). , 1973, British medical bulletin.
[41] Yong Li,et al. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus , 2009, Brain Research.
[42] H. Iwabuchi,et al. Studies on the sesquiterpenoids of Panax ginseng C. A. Meyer. II. Isolation and structure determination of ginsenol, a novel sesquiterpene alcohol. , 1988, Chemical & pharmaceutical bulletin.
[43] M. Bajda,et al. Multi-target-directed ligands in Alzheimer's disease treatment. , 2011, Current medicinal chemistry.
[44] Hyeon-Joong Kim,et al. Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration , 2015, Journal of ginseng research.
[45] C. Sung,et al. Long-term administration of ginsenoside Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. , 2014, International journal of molecular medicine.
[46] R. Dempsey,et al. Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. , 2003, Antioxidants & redox signaling.
[47] Jianming Lü,et al. Ginseng compounds: an update on their molecular mechanisms and medical applications. , 2009, Current vascular pharmacology.
[48] G. Wilcock,et al. The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.
[49] Y. Oshima,et al. Isolation and Hypoglycemic Activity of Panaxans F, G and H, Glycans of Panax ginseng Roots , 1985 .
[50] Zhiqiang Liu,et al. Ginsenosides attenuate d-galactose- and AlCl3-inducedspatial memory impairment by restoring the dysfunction of the neurotransmitter systems in the rat model of Alzheimer's disease. , 2016, Journal of ethnopharmacology.
[51] Lei Zheng,et al. Neuroprotective effects of pretreatment of ginsenoside Rb1 on severe cerebral ischemia‐induced injuries in aged mice: Involvement of anti‐oxidant signaling , 2017, Geriatrics & gerontology international.
[52] K. Kang,et al. Increase in apoptotic effect of Panax ginseng by microwave processing in human prostate cancer cells: in vitro and in vivo studies , 2015, Journal of ginseng research.
[53] H. Cho,et al. Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats. , 2005, Journal of ethnopharmacology.
[54] Khaled Radad,et al. Ginsenosides and Their CNS Targets , 2011, CNS neuroscience & therapeutics.
[55] S. Pyo,et al. Korean Red Ginseng inhibits apoptosis in neuroblastoma cells via estrogen receptor β-mediated phosphatidylinositol-3 kinase/Akt signaling , 2014, Journal of ginseng research.
[56] C. Yuan,et al. Ginseng and diabetes. , 2005, The American journal of Chinese medicine.
[57] J. Son,et al. Neuronal autophagy and neurodegenerative diseases , 2012, Experimental & Molecular Medicine.
[58] T. Yasuda,et al. Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. , 1996, Free radical biology & medicine.
[59] T. Sakata,et al. Attenuation of anorexia induced by heat or surgery during sustained administration of ginsenoside Rg1 into rat third ventricle , 2004, Psychopharmacology.
[60] M. Gurney,et al. Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.
[61] S. Humbert,et al. The Biology of Huntingtin , 2016, Neuron.
[62] Yong Tae Kwon,et al. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.
[63] K. Kang,et al. Beneficial effects of fermented black ginseng and its ginsenoside 20(S)-Rg3 against cisplatin-induced nephrotoxicity in LLC-PK1 cells , 2015, Journal of ginseng research.
[64] 이영철,et al. 인삼에 함유된 페놀성 성분의 신경세포보호 및 항염증 효과 , 2009 .
[65] Marios Politis,et al. Hypothalamic involvement in Huntington's disease: an in vivo PET study. , 2008, Brain : a journal of neurology.
[66] K. Chu,et al. Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease , 2012, Nutritional neuroscience.
[67] D. Holtzman,et al. Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease , 2015, Experimental & Molecular Medicine.
[68] N. Chen,et al. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease , 2015, Acta Pharmacologica Sinica.
[69] O. Hornykiewicz. How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago. , 2001, Wiener klinische Wochenschrift.
[70] D. Rhee,et al. Biological Activities and Chemistry of Saponins from Panax ginseng C. A. Meyer , 2005, Phytochemistry Reviews.
[71] Hwan-Suck Chung,et al. Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice , 2016, Experimental & Molecular Medicine.
[72] S. Fahn,et al. Should Levodopa Therapy for Parkinsonism be Started Early or Late? Evidence Against Early Treatment , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[73] Sung-Chun Tang,et al. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke , 2011, Molecular Neurodegeneration.
[74] B. D. Lee,et al. Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond , 2015, BMB reports.
[75] Seung-Hyun Kim,et al. Comparative phenolic compound profiles and antioxidative activity of the fruit, leaves, and roots of Korean ginseng (Panax ginseng Meyer) according to cultivation years , 2015, Journal of ginseng research.
[76] E. González-Burgos,et al. Potential Neuroprotective Activity of Ginseng in Parkinson’s Disease: A Review , 2014, Journal of Neuroimmune Pharmacology.
[77] Linfu Zhou,et al. Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia , 2012, Neurological Sciences.
[78] M. Won,et al. Immunohistochemical detection of oxidative DNA damage induced by ischemia–reperfusion insults in gerbil hippocampus in vivo , 1999, Brain Research.
[79] F. Walker. Huntington's disease , 2007, The Lancet.
[80] D. Butterfield,et al. Natural antioxidants in Alzheimer's disease , 2007, Expert opinion on investigational drugs.
[81] W. König,et al. Three sesquiterpene hydrocarbons from the roots of Panax ginseng C.A. Meyer (Araliaceae). , 2005, Phytochemistry.
[82] M. Muenter,et al. Multi‐center study of Parkinson mortality with early versus later dopa treatment , 1987, Annals of neurology.
[83] S. Fahn,et al. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.
[84] K. Takada,et al. Characterization of two acidic polysaccharides having immunological activities from the root of Panax ginseng. , 1993, Biological & pharmaceutical bulletin.
[85] S. Joo,et al. Reciprocal Activity of Ginsenosides in the Production of Proinflammatory Repertoire, and their Potential Roles in Neuroprotection in vitro , 2005, Planta medica.
[86] B. Aggarwal,et al. Neuroprotection by Spice-Derived Nutraceuticals: You Are What You Eat! , 2011, Molecular Neurobiology.
[87] Yifa Zhou,et al. Neuroprotective effects of ginseng pectin through the activation of ERK/MAPK and Akt survival signaling pathways. , 2012, Molecular medicine reports.
[88] Y. Mizuno,et al. Parkinson's disease: from etiology to treatment. , 1995, Internal medicine.
[89] Yifan Han,et al. Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. , 2011, Journal of ethnopharmacology.
[90] Y. Oshima,et al. Isolation and hypoglycemic activity of panaxans Q, R, S, T and U, glycans of Panax ginseng roots. , 1985, Journal of ethnopharmacology.
[91] W. Markesbery,et al. Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.
[92] H. Baik,et al. CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease , 2016, Experimental & Molecular Medicine.
[93] H. Iwabuchi,et al. Studies on the sesquiterpenoids of Panax ginseng C. A. Meyer. IV. , 1990, Chemical & pharmaceutical bulletin.
[94] Dong Zhou,et al. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[95] S. Kwon,et al. Chemical diversity of ginseng saponins from Panax ginseng☆ , 2015, Journal of ginseng research.
[96] L. B. Babiker,et al. INVESTIGATION OF STABILITY OF KOREAN GINSENG IN HERBAL DRUG PRODUCT , 2014 .
[97] Z. Dong,et al. Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury , 2015, International journal of molecular sciences.
[98] Sang Myung Lee,et al. Characterization of Korean Red Ginseng (Panax ginseng Meyer): History, preparation method, and chemical composition , 2015, Journal of ginseng research.
[99] K. Sugiyama,et al. Isolation and hypoglycaemic activity of panaxans A, B, C, D and E, glycans of Panax ginseng roots. , 1984, Planta medica.
[100] Dong-Hyun Kim,et al. Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. , 2013, Journal of ethnopharmacology.
[101] J. Parodi,et al. Amyloid pore-channel hypothesis: effect of ethanol on aggregation state using frog oocytes for an Alzheimer’s disease study , 2015, BMB reports.
[102] J-Y Wang,et al. Ginsenine, a new alkaloid from the berry of Panax ginseng C. A. Meyer , 2006, Journal of Asian natural products research.
[103] M. Nagai,et al. STUDIES ON THE CONSTITUENTS OF JAPANESE AND CHINESE CRUDE DRUGS. XII. PANAXADIOL, A SAPOGENIN OF GINSENG ROOTS. , 1963, Chemical & pharmaceutical bulletin.
[104] A. Rosenblatt. Neuropsychiatry of Huntington's disease , 2007, Dialogues in clinical neuroscience.
[105] Yadong Huang,et al. Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives , 2015, Experimental & Molecular Medicine.
[106] H. Heinsen,et al. The Neuropathology of Huntington’s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy , 2015, Advances in Anatomy, Embryology and Cell Biology.
[107] P. Xiao,et al. Recent advances on ginseng research in China. , 1992, Journal of ethnopharmacology.
[108] S. Yim,et al. Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells , 2015, Journal of ginseng research.
[109] I. Cho. Effects of Panax ginseng in Neurodegenerative Diseases , 2012, Journal of ginseng research.
[110] D. Baker,et al. Inflammation in neurodegenerative diseases , 2010, Immunology.
[111] Dongsun Park,et al. Suppressive effects of red ginseng preparations on SW480 colon cancer xenografts in mice , 2011 .
[112] K. Kang,et al. Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism , 2013, Journal of ginseng research.